Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Global Cord Blood

NYSE CO
$1.13 0.05 4.42%
Today share price
Hong Kong
Sector: Healthcare Industry: Health Care Providers & Services
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 24 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

3.02B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-3.64B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.42
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
2.67B
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-

Upcoming events Global Cord Blood

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Global Cord Blood

Stock analysis Global Cord Blood

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
6.40 18.83
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
0.62 2.13
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
- 10.47
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
- 2.24
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
61.25 10.15

Price change Global Cord Blood per year

3.46$ 6.31$
Min Max

Summary analysis Global Cord Blood

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Global Cord Blood

Revenue and net income Global Cord Blood

All parameters

Stock news Global Cord Blood

All news
17 June 2022 в 19:25

Global Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for IND

17 June 2022 в 19:25

Global Cord Blood Shares Rise 15% After Merger Target Gets FDA Clearance for IND

29 April 2022 в 23:51

Global Cord Blood Corp. Agrees to Acquire Cellenkos

29 April 2022 в 23:45

Global Cord Blood Corp. Agrees to Acquire Cellenkos

1 March 2022 в 21:37

Global Cord Blood Shares Gain 11% on 3Q Results

1 March 2022 в 21:37

Global Cord Blood Shares Gain 11% on 3Q Results

15 February 2022 в 20:45

Global Cord Blood Corp. Shares Rise 15% on Potential HIV Cure News

15 February 2022 в 20:45

Global Cord Blood Corp. Shares Rise 15% on Potential HIV Cure News

About company Global Cord Blood

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2021, it operated three cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
Address:
Bank of China Tower, Central, Hong Kong
Company name: Global Cord Blood
Issuer ticker: CO
ISIN: KYG393421030
Country: Hong Kong
Exchange: NYSE
Currency: $
IPO date: 2007-05-09
Sector: Healthcare
Industry: Health Care Providers & Services
Site: https://www.globalcordbloodcorp.com

On which stock exchange are Global Cord Blood (CO) stocks traded?

Global Cord Blood (CO) stocks are traded on NYSE.

What is the ticker of Global Cord Blood stocks (CO)?

The stock ticker of Global Cord Blood’s stocks or in other words, the code is CO. The stocks are currently listed on the NYSE exchange.

In which sector and industry does Global Cord Blood (CO) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Global Cord Blood (CO) belongs to the «Healthcare» sector and the «Health Care Providers & Services» industry.

In what currency are Global Cord Blood (CO) stocks traded?

Global Cord Blood (CO) stocks are traded on the NYSE exchange in dollars.

What is the price of Global Cord Blood (CO) stocks today?

The current price of Global Cord Blood stocks on 16.05.2024 is 1.13 dollars. per share.

What is the dynamics of Global Cord Blood (CO) stocks from the beginning of the year?

Global Cord Blood (CO) quotes have increased by 0% from the beginning of the year up to 1.13 dollars. per 1 stocks.

How much did Global Cord Blood (CO) stocks increase in мае 2024?

This month Global Cord Blood (CO) quotes have increased by 0% to 1.13 dollars. per share.

How much are Global Cord Blood (CO) stocks worth?

Today, on October, 16.05.2024 Global Cord Blood’s (CO) stocks cost 1.13 dollars..

What is the market capitalization of Global Cord Blood (CO)?

Capitalization is the market value of Global Cord Blood (CO) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 16.05.2024, the market capitalization of Global Cord Blood (CO) is estimated at about 3017043500 dollars.